Search research articles
Contact Us
Filters
Showing results (51-60 of 121) with videos related to
Page
of 13
Sort By:
Advances in Therapy
|
April 22, 2022
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
Sanjay Chabra, B J Gill, Gaia Gallo, et al.
JAMA Dermatology
|
February 6, 2020
Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis
April W Armstrong, Luis Puig, Avani Joshi, et al.
Acta Dermato-Venereologica
|
September 21, 2017
Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension
Alexandra B Kimball, Thomas Luger, Alice Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 18, 2023
Price variability of TNF-α inhibitor biosimilars among European countries
Davide Geat, Paolo Gisondi, Martina Maurelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 8, 2023
The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study
Marie Aleth Richard, Carle Paul, Tamar Nijsten, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 8, 2023
Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project
Paolo Gisondi, Luis Puig, Marie Aleth Richard, et al.
The Journal of Dermatological Treatment
|
August 12, 2017
Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial
April Armstrong, Luis Puig, Richard Langley, et al.
Dermatology and Therapy
|
November 29, 2023
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan
Yayoi Tada, Ahmed M Soliman, Kanako Ishii, et al.
Therapeutic Advances in Chronic Disease
|
April 15, 2021
Nomenclature and clinical phenotypes of atopic dermatitis
Giampiero Girolomoni, Marjolein de Bruin-Weller, Valeria Aoki, et al.
Expert Opinion on Biological Therapy
|
May 21, 2025
The 'totality of evidence' and 'extrapolation' of SB17, a ustekinumab biosimilar
Jae Hee Cheon, Byong Duk Ye, Alessandro Armuzzi, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 121) with videos related to
Sort By:
Page
of 13
Advances in Therapy
|
April 22, 2022
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
Sanjay Chabra, B J Gill, Gaia Gallo, et al.
JAMA Dermatology
|
February 6, 2020
Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis
April W Armstrong, Luis Puig, Avani Joshi, et al.
Acta Dermato-Venereologica
|
September 21, 2017
Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term Extension
Alexandra B Kimball, Thomas Luger, Alice Gottlieb, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 18, 2023
Price variability of TNF-α inhibitor biosimilars among European countries
Davide Geat, Paolo Gisondi, Martina Maurelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 8, 2023
The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study
Marie Aleth Richard, Carle Paul, Tamar Nijsten, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 8, 2023
Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project
Paolo Gisondi, Luis Puig, Marie Aleth Richard, et al.
The Journal of Dermatological Treatment
|
August 12, 2017
Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial
April Armstrong, Luis Puig, Richard Langley, et al.
Dermatology and Therapy
|
November 29, 2023
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan
Yayoi Tada, Ahmed M Soliman, Kanako Ishii, et al.
Therapeutic Advances in Chronic Disease
|
April 15, 2021
Nomenclature and clinical phenotypes of atopic dermatitis
Giampiero Girolomoni, Marjolein de Bruin-Weller, Valeria Aoki, et al.
Expert Opinion on Biological Therapy
|
May 21, 2025
The 'totality of evidence' and 'extrapolation' of SB17, a ustekinumab biosimilar
Jae Hee Cheon, Byong Duk Ye, Alessandro Armuzzi, et al.
Page
of 13